IGIL targets 20% EBITDA growth in FY27 as LGD expansion, AGL integration take shape
Management guided 15% revenue and 20% EBITDA growth for FY27, with clarity on lab-grown diamond capacity and the AGL acquisition synergy timeline.
What's new
- FY27 guidance: 15% revenue, 20% EBITDA growth
- LGD capacity expansion plans detailed in concall
- AGL acquisition integration progress and expected synergies
Why this matters
Mid-cap gems & jewellery firms rarely give explicit annual guidance. IGIL's 15/20 target signals confidence in LGD and AGL-led growth, but execution risk remains high in a volatile diamond market.
What we're watching
- Monthly LGD certification volumes — early indicator of demand
- AGL's revenue contribution in H1FY27
- Any deviation from the 20% EBITDA margin trajectory
The full read
IGIL's concall did more than recap results — it laid out a two-year roadmap. Management guided 15% revenue and 20% EBITDA growth for FY27, backed by a lab-grown diamond (LGD) capacity expansion that will double certification throughput by Q3FY27. The AGL acquisition, closed last quarter, is on track to add ₹35 cr in annual revenue from FY27 onwards, with cross-sell synergies emerging in the US. The guidance is rare for this mid-cap — most peers offer only qualitative outlook. While the targets are achievable if end-consumer demand holds, the diamond industry is notorious for supply-chain volatility. IGIL is betting that LGD certification becomes a recurring, higher-margin business and that AGL's US presence opens a wider moat. The next two quarters will test whether the execution matches the ambition.